Managing Privacy: The Imperative RWE Capability
Take the lead in Real-World Evidence Privacy Management Leveraging real-world evidence (RWE) solutions are essential to driving new insights in…
The 2016-2017 State of Data Sharing
When we first conducted the original State of Data Sharing for Healthcare Analytics, we did not expect the response we…
Opportunities Found in Learning Healthcare Systems
The desire to prevent medical errors, enforce best practice guidelines and limit inefficiency is shaping the healthcare industry’s future. To…
RWE and Risk: A Primer
Balancing the Demand for Deep Data with Patient Privacy As pharma companies have become more sophisticated in their use of…
Unlocking Big Data for Healthcare
There are powerful opportunities facing healthcare today. Big Data Analytics (BDA) is being leveraged by a broad spectrum of healthcare…
Strengthening Secondary Use
How Registries Can Responsibly Share Data Data registries are an invaluable tool that require the secondary use of data for…
Achieving Clinical Trials Transparency
Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials…
The 21st Century Cures Act: Help or Hinder?
The 21st Century Cures Act has implications for research and privacy in healthcare. Will it help or hinder using data for secondary purposes?
The State of Data Sharing for Healthcare Analytics
A comprehensive and informative survey on data sharing, protection and analytics in healthcare – get your copy today!
What’s the Risk?
Six ways Privacy Officers can limit risk exposure when sharing or monetizing data assets.
Avoid the Blur of Data Masking
Don’t blur the lines between data masking and real de-identification; learn more in this Privacy Analytics white paper.
Safe Harbor Versus The Statistical Method
Understand more about the key differences between Safe Harbor and the Statistical Method under HIPAA’s privacy rule in this white paper.